Cyst Global Clinical Trials Review, H1, 2019

2019-04-30
Price :
Published : Apr-2019
No. of Pages : 67

Cyst Global Clinical Trials Review, H1, 2019

Summary

GlobalData’s clinical trial report, “Cyst Global Clinical Trials Review, H1, 2019” provides an overview of Cyst clinical trials scenario. This report provides top line data relating to the clinical trials on Cyst. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Women’s Health Care Market by Drugs (Prolia, Xgeva, Evista, Mirena, Zometa, Reclast, Nuvaring, Primarin, Actonel), Application (Female Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraception, PCOS, Menopause) – Global forecast to 2024

“Growing incidence of chronic health conditions among women and the demand in contraceptives to prevent unintended pregnancies are the key factors driving the women’s healthcare market.” The global women’s healthcare market is projected to reach USD 17.8 billion by 2024 from USD 9.6 billion in 2019, at a CAGR of 13.2% during the forecast period. Growth in this market is mainly driven by the growing incidence of chronic health conditions among women, growing demand for contraceptives to prevent unintended pregnancies, growing focus on R&D by key players for the development of advanced products, and the government initiatives to curb population growth. On the other hand, the reluctance to use contraceptives is a major factor limiting the market growth. “Prolia is the larg......
$5650

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – United Arab Emirates

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates Summary GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape -UAE". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the UAE. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape, and healthcare infrastructure of the UAE. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-h......
$1995

Stable Isotope Labeled Compounds Market by Type (Carbon 13, D, Oxygen 18, N15), Application (Research, Clinical Diagnostics, Industrial), End User (Pharmaceutical & Biopharmaceutical Companies, Academic institute), Region – Global Forecast to 2024

“The stable isotope labeled compounds market is projected to grow at a CAGR of 3.0% during the forecast period (2019–2024).” The global stable isotope labeled compounds market size is projected to reach USD 312 million by 2024 from USD 269 million in 2019, at a CAGR of 3.0%. The growth of this market is driven majorly by factors such as the increase in research activities in the pharmaceutical and biotechnology sector, rising proteomics research, and the rising prevalence of cancer. However, the high cost of stable isotope-labeled compounds is expected to restrain the growth of this market during the forecast period. “By type, the H-2 labeled compounds segment is expected to grow at the highest CAGR during the forecast period.” Based on component, the stable isotope-labe......
$5650

North American Healthcare IT Market by Product (EHR, RIS, PACS, VNA, CPOE, HIE, PHM CRM, RCM, Telehealth, Healthcare Analytics, Supply Chain Management, mHealth, Fraud Analytics, Medication & Claims Management) End User (Provider,Payer) – Forecast to 2025

“North America healthcare IT market size to grow at a 16.4% CAGR” The North America healthcare IT market size is projected to reach USD 239.9 billion by 2025 from USD 96.3 billion in 2019, at a CAGR of 16.4%. There is a growing inclination across the globe towards the adoption of healthcare technologies due to the increasing need to deliver quality care to patients while curtailing escalating costs. These robust IT solutions are designed to streamline workflow in healthcare systems, reduce expenses, and facilitate compliance with stringent regulatory guidelines. “Based on products and services, the healthcare providers segment accounted for the largest share of the North America Healthcare IT market in 2018” Based on products and services, the market is segmented into heal......
$6150

Seasonal Influenza: Epidemiology Forecast in Asia-Pacific Markets to 2028

Seasonal Influenza: Epidemiology Forecast in Asia-Pacific Markets to 2028 Summary Seasonal influenza is a contagious respiratory viral illness. There are four types of seasonal influenza viruses (A, B, C, and D); however, only types A and B cause human disease of public health concern. Influenza transmission occurs when people with flu cough, sneeze, or talk and disseminate droplets. These droplets can land in the mouths or noses of people who then inhale them into the lungs. GlobalData epidemiologists identified country-specific population-based studies published in peer-reviewed journal articles and government-collated surveillance data to build the influenza forecast, and utilized appropriate proxy data where applicable. In 2018, there were 18,518,017 cases of lab-confirmed seasonal ......
$3495

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Colombia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia Summary GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the Colombia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the Colombia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and i......
$1995

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Malaysia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia Summary GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Malaysia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Malaysia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house ......
$1995

Seasonal Influenza Vaccines: Forecast in Asia-Pacific Markets to 2028

Seasonal Influenza Vaccines: Forecast in Asia-Pacific Markets to 2028 Summary Seasonal influenza is a viral infection that occurs annually in the winter months from December to March/April in the Northern Hemisphere and from May to August/September in the Southern Hemisphere, though most of India follows Southern Hemisphere seasonality Two types of influenza virus, type A and B, are responsible for the majority of seasonal influenza infections in humans, and due to frequent virus mutations annual vaccination is recommended. The WHO estimates three to five million cases of severe seasonal influenza infections and 290,000 to 650,000 influenza-related respiratory deaths, most of them in the elderly population. Therefore, many countries recommend annual immunization against seasonal influenz......
$8995

Chronic Obstructive Pulmonary Disease: Epidemiology Forecast to 2028

Chronic Obstructive Pulmonary Disease: Epidemiology Forecast to 2028 Summary Chronic Obstructive Pulmonary Disease (COPD) is a progressive disease characterized by coughing that produces large amounts of mucus, difficulty in breathing, shortness of breath (initially with exertion), wheezing, chest tightness, and other respiratory symptoms. The disease is diagnosed based on symptoms and the results of spirometry testing, which measures how deeply a person breathes and how fast air moves in and out of the lungs (World Health Organization, 2017). Spirometry results can also be used to determine the severity of COPD. The most commonly used severity criteria is the Global Initiative for Chronic Obstructive Lung Disease (GOLD) standard. GlobalData epidemiologists utilized county-specific stud......
$3995

Multiple Sclerosis – Global Drug Forecast and Market Analysis to 2028

Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2028 Summary MS is a primary autoimmune disease with a mechanism involving recurrent inflammatory attacks on the central nervous system (CNS) due to a dysfunctional immune system, leading to neurological disability . The exact underlying cause of the inflammatory autoimmune process remains unknown; however, it is widely believed that MS results from a complex interaction of genetic susceptibility and environmental factors. MS is primarily considered an inflammatory demyelinating disorder of the CNS, and is characterized by lymphocyte and macrophage infiltrates, as well as glial cell activation. The key pathological finding in MS neural tissue is the presence of diffuse inflammatory lesions, also known as plaques, which are......
$10995
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy